NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing brain-penetrant therapeutics for central nervous system (CNS) cancers, today announced newly ...

Patients with the deadliest form of brain cancer who received a focused ultrasound treatment to aid drug delivery increased their odds of survival by nearly 40%, according to research led by ...

Phase I clinical trials remain essential for new drug development, identifying new treatment pathways, and identifying ...

A new Lancet study examines the potential for ‘microbubble-enhanced ultrasound,’ which helps therapeutics enter the brain ...

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with ...

What lies beneath the surface? Ultrasound is revealing the earliest signs of psoriatic arthritis, and changing care in the ...

The funding will support the company's first-in-human clinical trial of its focused ultrasound platform designed to safely and temporarily open the blood-brain barrier (BBB). This capability could ...

Background The pathogenesis of the Osgood-Schlatter's disease (OSD) is still debated. The fragmentation of the ossification centre has been questioned as a definitive sign of OSD and has been seen as ...

The Department of Emergency Medicine offers a one-year Advanced Emergency Ultrasound Fellowship for qualified applicants who have successfully completed an accredited emergency medicine residency ...